Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
This article examines conceptual limitations of extant accounts of palliative psychiatry, with a focus on obligations to distinguish among and clearly formulate goals of care.
AMA J Ethics. 2023;25(9):E710-717. doi:
10.1001/amajethics.2023.710.
The default principle—that someone is free to do what he or she desires in the absence of a compelling reason why he or she should not—may make it possible to resolve ethical disputes without recourse to a particular moral framework.
AMA J Ethics. 2015;17(4):289-296. doi:
10.1001/journalofethics.2015.17.4.spec1-1504.
Fabian von Knoch, MD, Anthony Marchie, MD, MPhil, and Henrik Malchau, MD, PhD
An argument that national joint registries have improved outcomes for arthroplasty patients because they track device performance, reduce revision surgeries, and promote evidence-based surgery.